No vendor money.
Every other “peptide information” site is a sales funnel for an RUO vendor. That’s the structural problem. Here’s how we’re different and why it matters.
The pattern.
Most “free peptide dose calculator” sites are owned by — or affiliated with — an RUO peptide vendor. The math tool is the lead-gen mechanism: search brings you in for a calculator, vendor links convert you on the way out.
You can usually spot it within 30 seconds. Check the footer for “a [Vendor Name] resource.” Check the “Where to buy” sidebar. Check whether the dose recommendations conveniently match what their parent vendor sells.
The problem with that.
Three things bend when content lives downstream of a sales funnel:
- Coverage gap. Vendor-owned sites only meaningfully cover what the vendor sells. Anything outside the catalog gets a thin entry or none.
- Suppressed signals.Negative news — CRLs, safety re-analyses, retracted papers, withdrawn trials — gets quietly omitted when it would hurt the vendor’s margin. The MK-677 CHF re-analysis is a good test case. Search for it.
- Sourcing dishonesty.A US-RUO-affiliated site cannot acknowledge that the same molecules sell for 5–10× less from overseas raws. That would destroy their parent’s margin. So they pretend the gray market doesn’t exist.
What we don't take.
- · Vendor partnerships, formal or informal
- · Affiliate links to any peptide vendor in any tier
- · Comped product or vials “for review”
- · Sponsored content, native ads, or paid placement
- · Display advertising
- · Telehealth-platform commissions
- · Compounding-pharmacy referral fees
- · Newsletter sponsorships from anyone selling anything we cover
What we do take.
The membership. $19 once for a single-peptide report, or $99 once for all 59 — both yours forever, no rebill. $29/mo for Pro (full deep-dive on all 59peptides plus the Stack Builder math, journal, goals, bloodwork, and watchlist alerts). Stripe-only. That’s the entire revenue model.
Members fund the work. That’s the firewall. When subscribers pay for the editorial product, the editorial product can be honest about every tier of the supply chain, including the gray market that no vendor-affiliated site will name.
What you can verify.
The site has zero outbound affiliate links. Inspect the URLs — every “where to buy” on the sourcing pages describes a categoryof vendor (US RUO reseller, 503A pharmacy, gray-market raws via Discord), never names a specific one. The names are deliberately omitted because the second we publish a name, we’re either endorsing them or driving them business.
Read the sourcing guide → and check for yourself.
The editorial promise.
We will surface safety signals about peptides we’d sell if we sold peptides. We will tell you the gray market is cheaper. We will tell you the $300/mo RUO vial is the same molecule as the $5/mo factory raw. We will tell you when a peptide has no human trial data and we refuse to pre-fill a dose for it.
None of this is brave. It’s just what an unaffiliated reference looks like.